Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer

NCT06015035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Sintilimab and Anlotinib in Combination With Chemotherapy

Interventions

DRUG: Sintilimab and anlotinib in combination with chemotherapy

Sponsor

Tang-Du Hospital